|
CCDC107 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.12790000000607E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.32910000000009E-05 |
| Normal-vs-Stage2 |
2.710600E-01 |
| Normal-vs-Stage3 |
3.224600E-01 |
| Normal-vs-Stage4 |
3.437200E-01 |
| Stage1-vs-Stage2 |
2.125600E-01 |
| Stage1-vs-Stage3 |
6.795200E-03 |
| Stage1-vs-Stage4 |
4.910000E-01 |
| Stage2-vs-Stage3 |
6.422800E-01 |
| Stage2-vs-Stage4 |
8.325000E-01 |
| Stage3-vs-Stage4 |
6.049800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07079999999804E-05 |
| Normal-vs-AfricanAmerican |
1.235850E-02 |
| Normal-vs-Asian |
9.632000E-01 |
| Caucasian-vs-AfricanAmerican |
5.640600E-01 |
| Caucasian-vs-Asian |
1.711380E-01 |
| AfricanAmerican-vs-Asian |
7.688100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6829000000218E-06 |
| Normal-vs-Female |
1.309570E-01 |
| Male-vs-Female |
6.980900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.355800E-03 |
| Normal-vs-Extreme_Weight |
7.50150000006222E-07 |
| Normal-vs-Obese |
3.557600E-03 |
| Normal-vs-Extreme_Obese |
8.738200E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.952400E-01 |
| Normal_Weight-vs-Obese |
6.678400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.537600E-01 |
| Extreme_Weight-vs-Obese |
1.352180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.234000E-01 |
| Obese-vs-Extreme_Obese |
7.171200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.635400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.160800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.10850000000163E-05 |
| Normal-vs-Age(81-100Yrs) |
8.007600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.706200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.826200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.430200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.170400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.05880004342663E-09 |
| Normal-VS-Type2 PRCC |
1.442850E-01 |
| Normal-VS-KIRP CIMP |
5.252100E-02 |
| Normal-VS-Unclassified PRCC |
1.482020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.215710E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.54860000168134E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
9.586100E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.219640E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.925600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.840240E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.119500E-03 |
| Normal-vs-N1 |
9.286800E-01 |
| Normal-vs-N2 |
2.804600E-01 |
| N0-vs-N1 |
2.041900E-02 |
| N0-vs-N2 |
7.430000E-01 |
| N1-vs-N2 |
4.550800E-01 |
|
|
